相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mitogen-Inducible Gene-6 is a Negative Regulator of Epidermal Growth Factor Receptor Signaling in Hepatocytes and Human Hepatocellular Carcinoma
Markus Reschke et al.
HEPATOLOGY (2010)
Targeting the EGFR and the PKB pathway in cancer
Shoshana Klein et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Chk1 is a histone H3 threonine 11 kinase that regulates DNA damage-induced transcriptional repression
Midori Shimada et al.
CELL (2008)
Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor
Jiefei Tong et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS
Udayan Guha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAFV600E positive papillary thyroid cancers
Daniel T. Ruan et al.
SURGERY (2008)
The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity
S. Anastasi et al.
ONCOGENE (2007)
Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface
Xuewu Zhang et al.
NATURE (2007)
Epidermal growth factor receptor pathway mitigates UVA-induced G2/M arrest in keratinocyte cells
Christine Jean et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Mig-6, signal transduction, stress response and cancer
Yu-Wen Zhang et al.
CELL CYCLE (2007)
Evidence that MIG-6 is a tumor-suppressor gene
Y-W Zhang et al.
ONCOGENE (2007)
CHK1 phosphorylates CDC25B during the cell cycle in the absence of DNA damage
Estelle Schmitt et al.
JOURNAL OF CELL SCIENCE (2006)
Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation
Ingvar Ferby et al.
NATURE MEDICINE (2006)
Depletion of Chk1 leads to premature activation of Cdc2-cyclin B and mitotic catastrophe
H Niida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mitogen-inducible gene 6 is an endogenous inhibitor of HGF/Met-induced cell migration and neurite growth
G Pante et al.
JOURNAL OF CELL BIOLOGY (2005)
Novel indication for cancer therapy: Chk1 inhibition sensitizes tumor cells to antimitotics
Z Xiao et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin
S Anastasi et al.
ONCOGENE (2005)
Lack of PTEN sequesters CHK1 and initiates genetic instability
J Puc et al.
CANCER CELL (2005)
Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes
S Amatschek et al.
CANCER RESEARCH (2004)
Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism
K Uto et al.
EMBO JOURNAL (2004)
Chk1 versus Cdc25 - Chking one's levels of cellular proliferation
MH Lam et al.
CELL CYCLE (2004)
Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding
MS Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Feedback inhibition by RALT controls signal output by the ErbB network
S Anastasi et al.
ONCOGENE (2003)
Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control
M Fiorini et al.
ONCOGENE (2002)
Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach
T O'Neill et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Mig-6 is a negative regulator of the epidermal growth factor receptor signal
PO Hackel et al.
BIOLOGICAL CHEMISTRY (2001)
The DNA damage response: putting checkpoints in perspective
BBS Zhou et al.
NATURE (2000)
Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain
L Fiorentino et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK - A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stress
A Makkinje et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Rapid destruction of human Cdc25A in response to DNA damage
N Mailand et al.
SCIENCE (2000)
分享论文
